208 related articles for article (PubMed ID: 33523764)
1. NEDD9 Is a Novel and Modifiable Mediator of Platelet-Endothelial Adhesion in the Pulmonary Circulation.
Alba GA; Samokhin AO; Wang RS; Zhang YY; Wertheim BM; Arons E; Greenfield EA; Lundberg Slingsby MH; Ceglowski JR; Haley KJ; Bowman FP; Yu YR; Haney JC; Eng G; Mitchell RN; Sheets A; Vargas SO; Seo S; Channick RN; Leary PJ; Rajagopal S; Loscalzo J; Battinelli EM; Maron BA
Am J Respir Crit Care Med; 2021 Jun; 203(12):1533-1545. PubMed ID: 33523764
[No Abstract] [Full Text] [Related]
2. NEDD9 targets
Samokhin AO; Stephens T; Wertheim BM; Wang RS; Vargas SO; Yung LM; Cao M; Brown M; Arons E; Dieffenbach PB; Fewell JG; Matar M; Bowman FP; Haley KJ; Alba GA; Marino SM; Kumar R; Rosas IO; Waxman AB; Oldham WM; Khanna D; Graham BB; Seo S; Gladyshev VN; Yu PB; Fredenburgh LE; Loscalzo J; Leopold JA; Maron BA
Sci Transl Med; 2018 Jun; 10(445):. PubMed ID: 29899023
[TBL] [Abstract][Full Text] [Related]
3. Activated Endothelial TGFβ1 Signaling Promotes Venous Thrombus Nonresolution in Mice Via Endothelin-1: Potential Role for Chronic Thromboembolic Pulmonary Hypertension.
Bochenek ML; Leidinger C; Rosinus NS; Gogiraju R; Guth S; Hobohm L; Jurk K; Mayer E; Münzel T; Lankeit M; Bosmann M; Konstantinides S; Schäfer K
Circ Res; 2020 Jan; 126(2):162-181. PubMed ID: 31747868
[TBL] [Abstract][Full Text] [Related]
4. Platelets are highly activated in patients of chronic thromboembolic pulmonary hypertension.
Yaoita N; Shirakawa R; Fukumoto Y; Sugimura K; Miyata S; Miura Y; Nochioka K; Miura M; Tatebe S; Aoki T; Yamamoto S; Satoh K; Kimura T; Shimokawa H; Horiuchi H
Arterioscler Thromb Vasc Biol; 2014 Nov; 34(11):2486-94. PubMed ID: 25169936
[TBL] [Abstract][Full Text] [Related]
5. SOX2 promotes hypoxia-induced breast cancer cell migration by inducing NEDD9 expression and subsequent activation of Rac1/HIF-1α signaling.
Wang Y; Bibi M; Min P; Deng W; Zhang Y; Du J
Cell Mol Biol Lett; 2019; 24():55. PubMed ID: 31462898
[TBL] [Abstract][Full Text] [Related]
6. Endothelial cells from pulmonary endarterectomy specimens possess a high angiogenic potential and express high levels of hepatocyte growth factor.
Naito A; Sakao S; Lang IM; Voelkel NF; Jujo T; Ishida K; Sugiura T; Matsumiya G; Yoshino I; Tanabe N; Tatsumi K
BMC Pulm Med; 2018 Dec; 18(1):197. PubMed ID: 30594174
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-Inducible Factor 1α Is a Critical Downstream Mediator for Hypoxia-Induced Mitogenic Factor (FIZZ1/RELMα)-Induced Pulmonary Hypertension.
Johns RA; Takimoto E; Meuchel LW; Elsaigh E; Zhang A; Heller NM; Semenza GL; Yamaji-Kegan K
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):134-44. PubMed ID: 26586659
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia does neither stimulate pulmonary artery endothelial cell proliferation in mice and rats with pulmonary hypertension and vascular remodeling nor in human pulmonary artery endothelial cells.
Yu L; Hales CA
J Vasc Res; 2011; 48(6):465-75. PubMed ID: 21691120
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia enhances platelet-derived growth factor signaling in the pulmonary vasculature by down-regulation of protein tyrosine phosphatases.
ten Freyhaus H; Dagnell M; Leuchs M; Vantler M; Berghausen EM; Caglayan E; Weissmann N; Dahal BK; Schermuly RT; Ostman A; Kappert K; Rosenkranz S
Am J Respir Crit Care Med; 2011 Apr; 183(8):1092-102. PubMed ID: 21177885
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary endothelial NEDD9 and the prothrombotic pathophenotype of acute respiratory distress syndrome due to SARS-CoV-2 infection.
Alba GA; Samokhin AO; Wang RS; Wertheim BM; Haley KJ; Padera RF; Vargas SO; Rosas IO; Hariri LP; Shih A; Thompson BT; Mitchell RN; Maron BA
Pulm Circ; 2022 Apr; 12(2):e12071. PubMed ID: 35599981
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic Modification of the von Willebrand Factor Promoter Drives Platelet Aggregation on the Pulmonary Endothelium in Chronic Thromboembolic Pulmonary Hypertension.
Manz XD; Szulcek R; Pan X; Symersky P; Dickhoff C; Majolée J; Kremer V; Michielon E; Jordanova ES; Radonic T; Bijnsdorp IV; Piersma SR; Pham TV; Jimenez CR; Vonk Noordegraaf A; de Man FS; Boon RA; Voorberg J; Hordijk PL; Aman J; Bogaard HJ
Am J Respir Crit Care Med; 2022 Apr; 205(7):806-818. PubMed ID: 35081007
[No Abstract] [Full Text] [Related]
12. Characterization of proximal pulmonary arterial cells from chronic thromboembolic pulmonary hypertension patients.
Quarck R; Wynants M; Ronisz A; Sepulveda MR; Wuytack F; Van Raemdonck D; Meyns B; Delcroix M
Respir Res; 2012 Mar; 13(1):27. PubMed ID: 22452949
[TBL] [Abstract][Full Text] [Related]
13. NEDD9, a Hypoxia-upregulated Mediator for Pathogenic Platelet-Endothelial Cell Interaction in Pulmonary Hypertension.
Wang J; Yang K; Yuan JX
Am J Respir Crit Care Med; 2021 Jun; 203(12):1455-1458. PubMed ID: 33770456
[No Abstract] [Full Text] [Related]
14. Periostin: A Potential Therapeutic Target For Pulmonary Hypertension?
Nie X; Shen C; Tan J; Wu Z; Wang W; Chen Y; Dai Y; Yang X; Ye S; Chen J; Bian JS
Circ Res; 2020 Oct; 127(9):1138-1152. PubMed ID: 32752980
[TBL] [Abstract][Full Text] [Related]
15. ICAM-1 promotes the abnormal endothelial cell phenotype in chronic thromboembolic pulmonary hypertension.
Arthur Ataam J; Mercier O; Lamrani L; Amsallem M; Arthur Ataam J; Arthur Ataam S; Guihaire J; Lecerf F; Capuano V; Ghigna MR; Haddad F; Fadel E; Eddahibi S
J Heart Lung Transplant; 2019 Sep; 38(9):982-996. PubMed ID: 31324443
[TBL] [Abstract][Full Text] [Related]
16. NF-κB pathway is involved in CRP-induced effects on pulmonary arterial endothelial cells in chronic thromboembolic pulmonary hypertension.
Wynants M; Vengethasamy L; Ronisz A; Meyns B; Delcroix M; Quarck R
Am J Physiol Lung Cell Mol Physiol; 2013 Dec; 305(12):L934-42. PubMed ID: 24097561
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-inducible factor-1 α/platelet derived growth factor axis in HIV-associated pulmonary vascular remodeling.
Mermis J; Gu H; Xue B; Li F; Tawfik O; Buch S; Bartolome S; O'Brien-Ladner A; Dhillon NK
Respir Res; 2011 Aug; 12(1):103. PubMed ID: 21819559
[TBL] [Abstract][Full Text] [Related]
18. Circulating NEDD9 is increased in pulmonary arterial hypertension: A multicenter, retrospective analysis.
Samokhin AO; Hsu S; Yu PB; Waxman AB; Alba GA; Wertheim BM; Hopkins CD; Bowman F; Channick RN; Nikolic I; Faria-Urbina M; Hassoun PM; Leopold JA; Tedford RJ; Ventetuolo CE; Leary PJ; Maron BA
J Heart Lung Transplant; 2020 Apr; 39(4):289-299. PubMed ID: 31952977
[TBL] [Abstract][Full Text] [Related]
19. Derivation and characterisation of endothelial cells from patients with chronic thromboembolic pulmonary hypertension.
Tura-Ceide O; Smolders VFED; Aventin N; Morén C; Guitart-Mampel M; Blanco I; Piccari L; Osorio J; Rodríguez C; Rigol M; Solanes N; Malandrino A; Kurakula K; Goumans MJ; Quax PHA; Peinado VI; Castellà M; Barberà JA
Sci Rep; 2021 Sep; 11(1):18797. PubMed ID: 34552142
[TBL] [Abstract][Full Text] [Related]
20. Effects of C-reactive protein on human pulmonary vascular cells in chronic thromboembolic pulmonary hypertension.
Wynants M; Quarck R; Ronisz A; Alfaro-Moreno E; Van Raemdonck D; Meyns B; Delcroix M
Eur Respir J; 2012 Oct; 40(4):886-94. PubMed ID: 22267767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
